MAIA Biotechnology Inc. (MAIA)
MAIA Biotechnology Statistics
Share Statistics
MAIA Biotechnology has 29.59M shares outstanding. The number of shares has increased by 85.91% in one year.
Shares Outstanding | 29.59M |
Shares Change (YoY) | 85.91% |
Shares Change (QoQ) | 5.96% |
Owned by Institutions (%) | 5.79% |
Shares Floating | 21.55M |
Failed to Deliver (FTD) Shares | 3.85K |
FTD / Avg. Volume | 1.34% |
Short Selling Information
The latest short interest is 662.41K, so 2.61% of the outstanding shares have been sold short.
Short Interest | 662.41K |
Short % of Shares Out | 2.61% |
Short % of Float | 3.15% |
Short Ratio (days to cover) | 10.99 |
Valuation Ratios
The PE ratio is -1.89 and the forward PE ratio is -1.38. MAIA Biotechnology's PEG ratio is 0.06.
PE Ratio | -1.89 |
Forward PE | -1.38 |
PS Ratio | 0 |
Forward PS | 0.2 |
PB Ratio | 12.09 |
P/FCF Ratio | -2.8 |
PEG Ratio | 0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for MAIA Biotechnology Inc..
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.65, with a Debt / Equity ratio of 0.
Current Ratio | 2.65 |
Quick Ratio | 2.65 |
Debt / Equity | 0 |
Total Debt / Capitalization | 0 |
Cash Flow / Debt | 0 |
Interest Coverage | 297494.91 |
Financial Efficiency
Return on equity (ROE) is -6.4% and return on capital (ROIC) is -466.54%.
Return on Equity (ROE) | -6.4% |
Return on Assets (ROA) | -2.29% |
Return on Capital (ROIC) | -466.54% |
Revenue Per Employee | $0 |
Profits Per Employee | $-1,788,819.69 |
Employee Count | 13 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -24.55% in the last 52 weeks. The beta is 0.21, so MAIA Biotechnology's price volatility has been higher than the market average.
Beta | 0.21 |
52-Week Price Change | -24.55% |
50-Day Moving Average | 1.81 |
200-Day Moving Average | 2.55 |
Relative Strength Index (RSI) | 43.91 |
Average Volume (20 Days) | 287.27K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -16.96M |
Net Income | -23.25M |
EBITDA | -16.96M |
EBIT | n/a |
Earnings Per Share (EPS) | -1.05 |
Balance Sheet
The company has 9.6M in cash and 0 in debt, giving a net cash position of 9.6M.
Cash & Cash Equivalents | 9.6M |
Total Debt | 0 |
Net Cash | 9.6M |
Retained Earnings | -87.23M |
Total Assets | 9.24M |
Working Capital | 5.63M |
Cash Flow
In the last 12 months, operating cash flow was -15.7M and capital expenditures 0, giving a free cash flow of -15.7M.
Operating Cash Flow | -15.7M |
Capital Expenditures | 0 |
Free Cash Flow | -15.7M |
FCF Per Share | -0.71 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MAIA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -63.25% |
FCF Yield | -31.97% |
Analyst Forecast
Currently there are no analyst rating for MAIA.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -18.73 |
Piotroski F-Score | 2 |